UNION KOREA PHARM CO (080720)

KOSDAQ · 2,725 KRW · As of Aug 26, 2026 close

Mkt Cap

21.6B

Rev (2025)

36.4B

Op Inc (2025)

-17.2B

Net Inc (2025)

-30.8B

52W

2K~2K

UNION KOREA PHARM CO operates in the Pharmaceuticals sector.

Legal name: UNION KOREA PHARM CO.,Ltd

In fiscal year 2025, UNION KOREA PHARM CO (080720) reported revenue of 36.4 billion KRW, down 29.1% from 51.3 billion KRW a year earlier.

Operating profit was -17.2 billion KRW and net income was -30.8 billion KRW in the same year.

As of the Aug 26, 2026 close, the market capitalization was 21.6 billion KRW.

These figures can be verified in the DART filing (receipt no. 20260331002001).

Year	Rev	Op Inc	Net Inc
2025	36.4B	-17.2B	-30.8B
2024	51.3B	-13.5B	-20.9B
2023	63.2B	-5.2B	-18.2B
2022	61.3B	1.3B	-932M
2021	48.3B	-10.6B	-11.1B

5 applicable out of 8 items

Trading Halt Period Change (Investor Protection)

Semi-Annual Review Adverse Opinion (Capital Erosion 50%+ or Equity Below 1B)

회생절차종결신청

Checks

5 of 8 checked items currently applicable.

Market Cap & Price: Market cap is above the delisting threshold.

Administrative Designation: 2 administrative designation criteria met. [source]

Audit Opinion: Audit opinion: Unqualified (clean).

Convertible Bonds: Convertible bonds outstanding with 0.06% potential dilution.

Capital Increase: 2 capital-increase filing(s) in the last 180 days. [source]

Treasury Stock: No treasury stock filings.

Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.

Major Shareholder Change: 2 major shareholder change(s) in the last 180 days. [source]

Market Action: 17 market action(s) (trading halt, delisting, etc.) recorded. [source]

These checks are mechanical tests of disclosed figures and do not constitute investment advice or recommendations.

Date	Filing
2026-08-27	Trading Halt Period Change (Investor Protection)
2026-08-14	Semi-Annual Review Adverse Opinion (Capital Erosion 50%+ or Equity Below 1B)
2026-08-14	회생절차종결신청
2026-08-14	Semi-Annual Report (2026.06)